Status:
UNKNOWN
Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones
Lead Sponsor:
Chiang Mai University
Conditions:
Ureteral Calculi
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a randomized double blind placebo-controlled study that will assess the efficacy of Tamsulosin oral-controlled absorption system (OCAS) 0.4 mg in the conjunctive medical treatment of distal ur...
Detailed Description
* patient will be randomized to receive placebo or Tamsulosin OCAS 0.4 mg 1 tablet OD for a maximum of 28 days or until the ureteral stone is passed and sodium diclofenac 50 mg twice a day, for 10 day...
Eligibility Criteria
Inclusion
- Male or female patient aged =\> 18 years.
- Patients who have distal ureteral stones with a size of 4-10 mm
- Written informed consent has been obtained.
Exclusion
- Patients with history of ureteral surgery
- Patients with urinary tract infection
- Patient with diabetes and peptic ulcer
- Patient with renal dysfunction (elevated of serum creatinine level)
- Patients with severe hydronephrosis
- Patients with history of passing stones
- Pregnancy
- Patients who desire to withdraw from the study
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01167062
Start Date
June 1 2010
Last Update
July 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maharat Nakhon Chiangmai Hospital
Muang, Chiangmai, Thailand, 50200